Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sitansu S Nanda

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|September 7, 2019
Hydroxyapatite-alginate Based Matrices for Drug DeliveryAmit K Nayak, Md Saquib Hasnain, Sitansu S Nanda, et al.
Current Drug Targets|August 27, 2022
Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon CarcinomaSitansu S Nanda, Md Imran Hossain, Heongkyu Ju, et al.
Current Drug Targets|February 10, 2021
GSK-3 Inhibitors in the Regulation and Control of Colon CarcinomaSitansu S Nanda, Md Imran Hossain, Heongkyu Ju, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|September 7, 2019
Hydroxyapatite-alginate Based Matrices for Drug DeliveryAmit K Nayak, Md Saquib Hasnain, Sitansu S Nanda, et al.
Current Drug Targets|August 27, 2022
Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon CarcinomaSitansu S Nanda, Md Imran Hossain, Heongkyu Ju, et al.
Current Drug Targets|February 10, 2021
GSK-3 Inhibitors in the Regulation and Control of Colon CarcinomaSitansu S Nanda, Md Imran Hossain, Heongkyu Ju, et al.
Pageof 1